Coport 25 mg Tablet contains Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, used primarily in the management of type 2 diabetes mellitus. It works by inhibiting the reabsorption of glucose from the kidneys, leading to increased glucose excretion in urine and consequently lowering blood sugar levels. This medication also helps in reducing the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease.